Ambrisentan is a diarylmethane compound that functions as an endothelin receptor antagonist. It is supplied as a pharmaceutical raw material for use in the manufacturing of finished dosage forms.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 177036-94-1
Methyl (2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoate
pharmaceutical intermediate
Bosentan
pharmaceutical raw material
2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-
pharmaceutical raw material
(4-Hydroxyphenyl)[3-(4-hydroxyphenyl)-1-benzothiophen-2-yl]methanone
pharmaceutical raw material
DOTA-TATE acetate
pharmaceutical raw material
Revaprazan hydrochloride
pharmaceutical raw material
(+/-)-ambrisentan
pharmaceutical raw material
(R)-ambrisentan
pharmaceutical raw material
(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid
OUJTZYPIHDYQMC-LJQANCHMSA-N
CC1=CC(=NC(=N1)O[C@H](C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C